Press Releases Ypsomed Group
Burgdorf – Ypsomed believes it has reached a turning point, expects sales to grow by around ten percent in the next business year and operating profit to almost double.
The operating profit of the Ypsomed Group for the 2012/13 business year is in line with previously announced expectations: cost savings enabled the diabetes specialist to maintain its operating profit margin at the previous year’s level of 2.0%. Operating profit (EBIT) amounted to CHF 4.8 million (previous year: CHF 5.1 million), although consolidated sales of goods and services fell by 1.6% to CHF 244.6 million. Ypsomed believes it has reached a turning point. It expects sales to grow by around ten percent in the next business year and operating profit to almost double.
